Lexpos News

Community Pharmacy England will be taking pharmacy owners’ priorities to key audiences throughout the upcoming political party conference season, continuing our work to influence national decision-makers. As the political parties gather for their annual conferences, our planned engagement programme will underline the potential of community pharmacy, highlighting that investment in the sector would lead to [...]

The post CPE to put pharmacy owners’ priorities centre stage this party conference season appeared first on Community Pharmacy England.

NHS Business Services Authority (NHSBSA) has confirmed that the following 8 Eucerin® products will be granted upward retrospective pricing adjustments because the manufacturer did not update their product NHS list prices on the NHS dictionary of medicines and devices (dm+d) when the new list price changes took effect at the end of 2025.  Following checks [...]

The post Retrospective pricing adjustments for Eucerin® products appeared first on Community Pharmacy England.

Ahead of the introduction of independent prescribing in CPCF services, Community Pharmacy England has raised concerns about the NHS IT arrangements. Note, the below comment was first quoted in P3pharmacy. Our Director of NHS Services, Alastair Buxton, said: “The interim IT arrangements for the rollout of prescribing within the CPCF are far from ideal, with [...]

The post Prescribing software concerns appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (18/09/2026) confirmed the following list of price concessions for September 2026: Drug Pack size Price concession Aripiprazole 10mg tablets 28 £1.99 Bisoprolol 10mg tablets 28 £0.95 Candesartan 2mg tablets 7 £2.07 Doxazosin 4mg tablets 28 £1.19 Levetiracetam 1g tablets 60 £4.17 Mirtazapine 30mg orodispersible tablets 30 [...]

The post September 2026 Price Concessions 3rd Update appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Clobazam Martindale Pharma 5 mg/5 mL and 10 mg/5 mL Oral Suspension 150ml (Martindale Pharmaceuticals Ltd) Drug alert number: EL(26)A/38 Date issued: 17 September 2026 Martindale Pharmaceuticals has informed the MHRA of an error with the linear barcode of some batches of Clobazam 5mg/5mL and 10mg/5mL Oral Suspension 150mL. DMRC [...]

The post MHRA Class 4 Medicines Defect Notification: Clobazam 5mg/5ml and 10mg/5ml oral suspension 150ml (Martindale Pharmaceuticals Ltd) appeared first on Community Pharmacy England.